Hiten Patel

Abstract Relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) remains a leading cause of cancer-related death in children and young adults. While CD19-directed chimeric antigen receptor T cell (CAR-T) therapy offers promise, high rates of long-term failure underscore the need to understand resistance mechanisms. Our studies found p53 inactivation promotes CAR-T resistance in human pre-B-ALL cell lines.

My CV is a PDF, and PDFs do not answer questions. So I built ask.hiten.dev: a streaming chat grounded in my actual career history, where a recruiter can ask "why should I hire you over another senior frontend engineer?" and get a real answer. The constraint that made it interesting: the total inference budget is zero. No OpenAI bill, no hosted vector DB, nothing. Here is what that actually took.

AUA American Urological Association BMI body mass index CAD coronary artery disease CKD chronic kidney disease CKD-EPI chronic kidney disease epidemiology collaboration CSS cancer-specific survival EBL estimated blood loss eGFR estimated glomerular filtration rate IQR interquartile range IR intervention radiologist NCSS non-cancer specific survival OS overall survival PN partial nephrectomy PVD peripheral vascular disease RCC renal cell carcinoma RMB renal mass biopsy RN radical nephrectomy...